RxDoctor Payments Data

Harsh Golwala, MD

Interventional Cardiology · Portland, ORNPI 1265743686

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.4%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Boston Scientific at 31.9% of the total. Among interventional cardiology clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$105,289in general payments, 2019–2025

Across 293 payments — averaging $359.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$34K
  • Medtronic$31K
  • Edwards Lifesciences$13K
  • Ancora Heart, Inc.$11K
  • Shockwave Medical, Inc$7K
  • Jenavalve Technology, Inc.$4K
  • plus $4K from 4 others
$1,213,293in research payments, 2019–2025

Across 79 payments — averaging $15,358 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$960K
  • Boston Scientific$240K
  • Edwards Lifesciences$14K

What the payments were for

  • Consulting fees$46,78244%
  • Speaking & faculty fees$18,41617%
  • Travel & lodging$25,66924%
  • Food & beverage$14,42314%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific59$33,583
Medtronic(2 entities)80$31,304
Edwards Lifesciences96$13,423
Ancora Heart, Inc.16$11,140
Shockwave Medical, Inc7$7,369
Jenavalve Technology, Inc.3$4,494
Siemens Medical Solutions USA, Inc.10$2,050
Abbott20$1,835
Cardiac Dimensions, Inc.1$77
Abiomed1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$105,289 in reported general payments places this provider in the 90th percentile of 68 interventional cardiology providers in Oregon.

See all interventional cardiology providers in Oregon

Medicare billing

Part B allowed, 2024
$149,695
Medicare patients
257
Services billed
669

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$10,988
ClopidogrelClopidogrel Bisulfate131$1,518

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →